| Issue |
Section |
Title |
File |
| Vol 83, No 6 (2011) |
Editorial |
Bronchial asthma and gastroesophageal reflux disease: view of the clinician and pathophysiologist |
|
| Vol 83, No 8 (2011) |
Editorial |
Helicobacter pylori: what schemes of eradication are essential today? |
|
| Vol 84, No 2 (2012) |
Editorial |
Autoimmune pancreatitis: current status |
|
| Vol 90, No 8 (2018) |
Editorial |
Modern achievements in the diagnosis and treatment of the refractory gastroesophageal reflux disease |
(Rus)
|
| Vol 90, No 8 (2018) |
Editorial |
Russian consensus on exoand endocrine pancreatic insufficiency after surgical treatment |
(Rus)
|
| Vol 90, No 8 (2018) |
Editorial |
Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study |
(Rus)
|
| Vol 90, No 8 (2018) |
Editorial |
Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection |
(Rus)
|
| Vol 90, No 5 (2018) |
Editorial |
High resolution manometry and new classification of esophageal motility disorders |
(Rus)
|
| Vol 90, No 8 (2018) |
Editorial |
Effectiveness of mebeverine in patients with post-cholecystectomy gastrointestinal spasm: results of prospective observational program “odyssey” |
(Rus)
|
| Vol 90, No 8 (2018) |
Editorial |
Pharmacotherapy of chronic pancreatitis in terms of current clinical recommendations |
(Rus)
|
| Vol 90, No 2 (2018) |
Editorial |
Features of the functional activity of macrophage link of immunity with gastroesophageal reflux disease depending on the type of reluctate: in vitro model |
(Rus)
|
| Vol 90, No 2 (2018) |
Editorial |
Evropeyskiy registr Helicobacter pylori (Hp-EuReg): analiz dannykh 2360 bol'nykh, poluchavshikh terapiyu pervoy linii v Rossii |
(Rus)
|
| Vol 90, No 2 (2018) |
Editorial |
The cardiovascular system in patients with functional and inflammatory bowel diseases |
(Rus)
|
| Vol 90, No 2 (2018) |
Editorial |
Cellular and molecular mechanisms of inflammation of esophageal mucosa under different clinical course of gastroesophageal reflux disease and its complications |
(Rus)
|
| Vol 91, No 2 (2019) |
Editorial |
European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years |
(Rus)
|
| Vol 91, No 2 (2019) |
Editorial |
Possibilities of therapeutic correction of hyperammonemia and minimal hepatic encephalopathy in patients with chronic hepatitis C at the pre-cirrhotic stage |
(Rus)
|
| Vol 91, No 2 (2019) |
Editorial |
Phenotype of obesity and gastroesophageal reflux disease in the context of comorbidity in patients with cardiovascular diseases |
(Rus)
|
| Vol 91, No 8 (2019) |
Editorial |
Current advances in the treatment of gastroesophageal reflux disease: a focus on esophageal protection |
(Rus)
|
| Vol 91, No 8 (2019) |
Editorial |
The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease |
(Rus)
|
| Vol 91, No 8 (2019) |
Editorial |
Efficacy of H. pylori eradication depending on genetic polymorphism of CYP2C19, MDR1 and IL-1β |
(Rus)
|
| Vol 91, No 8 (2019) |
Editorial |
Methanobrevibacter smithii in irritable bowel syndrome: a clinical and molecular study |
(Rus)
|
| Vol 92, No 1 (2020) |
Editorial |
The effectiveness of pancreatic enzyme replacement therapy using microencapsulated pancreatin preparations in the correction of nutritional status in patients with chronic pancreatitis: a prospective observational study |
(Rus)
|
| Vol 92, No 2 (2020) |
Editorial |
Diagnostic accuracy of predictive indexes of liver fibrosis in patients with chronic hepatitis C |
(Rus)
|
| Vol 92, No 8 (2020) |
Editorial |
Novel coronavirus infection COVID-19: extrapulmonary manifestations |
(Rus)
|
| Vol 92, No 8 (2020) |
Original articles |
Development of the Russian version of quality of life questionnaire in patients with GERD – GERD-HRQL |
(Rus)
|
| Vol 92, No 8 (2020) |
Original articles |
Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results |
(Rus)
|
| Vol 92, No 8 (2020) |
Consensuns |
Interdisciplinary consensus on Russian-language terminology of anorectal sphincterometry and profilometry |
(Rus)
|
| Vol 92, No 11 (2020) |
Original articles |
Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years |
(Rus)
|
| Vol 92, No 12 (2020) |
Articles |
The prevalence of sarcopenia in patients with chronic pancreatitis: a meta-analysis |
(Rus)
|
| Vol 92, No 12 (2020) |
Articles |
Prevalence of small bowel bacterial overgrowth in patients with functional dyspepsia: a meta-analysis |
(Rus)
|
| Vol 92, No 12 (2020) |
Articles |
Testing and validation of the Russian version of quality of life questionnaire in patients with GERD – GERD-HRQL |
(Rus)
|
| Vol 92, No 12 (2020) |
Articles |
Rebamipide: evidence base for use in gastroenterology |
(Rus)
|
| Vol 92, No 12 (2020) |
Articles |
Recommendations for the Protocol of functional examination of the anorectal zone and disorders classification: the International Anorectal Physiology Working Group consensus and Russian real-world practice |
(Rus)
|
| Vol 93, No 2 (2021) |
Original articles |
Efficacy of butyric acid inclusion in eradication regimens for Helicobacter pylori infection: a meta-analysis of controlled trials |
(Rus)
|
| Vol 93, No 4 (2021) |
Reviews |
Exocrine pancreas insufficiency: clinical significance and approaches to correction from evidence medicine |
(Rus)
|
| Vol 93, No 8 (2021) |
Editorial |
Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management |
(Rus)
|
| Vol 93, No 8 (2021) |
Original articles |
Prevalence and prognostic value of gastroenterological manifestations of COVID-19: data from the Russian University Clinic |
(Rus)
|
| Vol 93, No 8 (2021) |
Original articles |
Efficacy of trimebutine in the treatment of functional gastrointestinal disorders: an observational multicenter study |
(Rus)
|
| Vol 93, No 12 (2021) |
Original articles |
Complex assessment of esophageal acidification and motor function in patients with Barrett's esophagus on antisecretory therapy |
(Rus)
|
| Vol 93, No 11 (2021) |
Original articles |
Efficacy and safety of bulevirtide in patients with chronic hepatitis D and compensated cirrhosis |
(Rus)
|
| Vol 94, No 1 (2022) |
Original articles |
Multicenter study of gastroesophageal reflux disease symptoms prevalence in outpatients in Russia |
(Rus)
|
| Vol 94, No 2 (2022) |
Original articles |
The effectiveness of eradication therapy of the 1st line of Helicobacter pylori infection in patients with type 2 diabetes mellitus |
(Rus)
|
| Vol 94, No 8 (2022) |
GUIDELINES |
Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians |
(Rus)
|
| Vol 94, No 8 (2022) |
Original articles |
Composition of oropharyngeal microbiota in patients with COVID-19 of different pneumonia severity |
(Rus)
|
| Vol 94, No 8 (2022) |
Clinical notes |
Masks hiding mitochondrial neurogastrointestinal encephalomyopathy. Case report |
(Rus)
|
| Vol 94, No 9 (2022) |
Original articles |
Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III–IV Criteria |
(Rus)
|
| Vol 94, No 10 (2022) |
Original articles |
Efficacy of Saccharomyces boulardii CNCM I-745 probiotic drug in the prevention and treatment of diarrhea in hospitalized patients with new coronavirus infection COVID-19 |
(Rus)
|
| Vol 94, No 11 (2022) |
Reviews |
Liver disease during the pandemic of COVID-19 infection: prediction of the course and tactics of management: A review |
(Rus)
|
| Vol 94, No 12 (2022) |
Original articles |
Efficacy of esophagus protection in complex treatment of erosive gastroesophageal reflux disease: a systematic review and meta-analysis of controlled trials |
(Rus)
|
| Vol 94, No 12 (2022) |
Original articles |
Treatment of toxic hepatitis in COVID-19 patients |
(Rus)
|
| Vol 95, No 1 (2023) |
Original articles |
Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study |
(Rus)
|
| Vol 95, No 2 (2023) |
Original articles |
Effectiveness of empirical Helicobacter pylori eradication therapy with furazolidone in Russia: results from the European Registry on Helicobacter pylori Management (Hp-EuReg) |
(Rus)
|
| Vol 95, No 2 (2023) |
Original articles |
Comparative analysis of the intestinal microbiota in patients with exocrine pancreatic insufficiency of various severity |
(Rus)
|
| Vol 95, No 7 (2023) |
Reviews |
Diseases of the gastrointestinal tract in the context of COVID-19 infection: present and future challenges: A review |
(Rus)
|
| Vol 95, No 8 (2023) |
Editorial |
Drug-induced liver injury: diagnosis of exclusion |
(Rus)
|
| Vol 95, No 8 (2023) |
Original articles |
Assessment of body mass index in patients with chronic hepatitis C who received an effective antiviral therapy |
(Rus)
|
| Vol 95, No 8 (2023) |
Reviews |
Current status and prospects of using the prokinetic acotiamide in gastroenterology: A review |
(Rus)
|
| Vol 95, No 12 (2023) |
Reviews |
Inflammatory bowel diseases: Transformation of representations. A review |
(Rus)
|
| Vol 95, No 12 (2023) |
Editorial |
Study of the resistome of human microbial communities using a targeted panel of antibiotic resistance genes in COVID-19 patients |
(Rus)
|
| Vol 96, No 2 (2024) |
Consensuns |
Resolution of the Expert Forum "New therapeutic horizons of NAFLD" |
(Rus)
|
